Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

CBZ

CBIZ Q2 Report – Revenue Flat, Net Income Plunges 55.6%

CBIZ reported a mixed second quarter, with revenue essentially flat but profit and cash-flow measures moving sharply lower than a year earlier.

For the quarter ended June 30, total revenue was $682 million, down 0.2% from the prior-year period. Financial services revenue also slipped 0.2%. Net income fell to $19 million, a decline of 55.6%, while GAAP earnings per share dropped 53.0% to $0.31. Adjusted EBITDA came in at $103 million, down 14.3%, and adjusted diluted EPS declined 8.1% to $0.91.

For the first half of 2026, the picture was stronger on the top line and in reported earnings. Total revenue rose 0.6% to $1.531 billion, with financial services revenue up 1.1%. Net income increased 4.1% to $171 million, and GAAP EPS climbed 9.7% to $2.83. Adjusted diluted EPS improved 3.6% to $3.44, though adjusted EBITDA fell 3.8% to $347 million.

Cash generation improved significantly in the first half, with operating cash flow up $97 million and free cash flow up $99 million.

Management pointed to ongoing investments in integrating Marcum, expanding AI capabilities and refining its go-to-market approach. The company also said it completed the acquisition of Bindz, adding more than 250 India-based professionals and a global delivery platform.

CBIZ also announced it has entered into a definitive merger agreement with Grant Thornton in the U.S., in an all-cash deal valuing the company at $5.0 billion, or $55.00 per share. The transaction is expected to close in the fourth quarter of 2026. As a result, CBIZ withdrew its 2026 guidance and will not hold an earnings conference call. The market has reacted to these announcements by moving the company's shares 16.83% to a price of $54.56. If you want to know more, read the company's complete 8-K report here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS